Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Branded Generics Market: Oncology Therapeutic Application Segment Expected to Grow Significantly in Developed Markets over the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2026

Table of Content

Table Of Content

1. Executive Summary

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Generics Market Overview

3. Global Branded Generics Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
3.2.1. Value Chain

4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors – Relevance and Impact
4.7.Regulations
4.8.Porter Five Forces Model
4.9.Patennt expiries in 2016

5. Global Branded Generics Market Analysis and Forecasts, By Therapeutic Application Type 
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Therapeutic Application Type
5.3. Y-o-Y Growth Projections By Therapeutic Application Type
5.4. Market Value Forecast By Therapeutic Application Type , 2016–2026
5.4.1. Oncology
5.4.2. Cardiovascular Diseases
5.4.3. Diabetes
5.4.4. Neurology
5.4.5. Gastrointestinal Diseases
5.4.6. Dermatology Diseases
5.4.7. Analgesics and Anti-inflammatory
5.4.8. Others
5.5. Prominent Trends
5.6. Market Attractiveness By Therapeutic Application Type 

6. Global Branded Generics Market Analysis and Forecasts, By Distribution Channel 
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Distribution Channel 
6.3. Y-o-Y Growth Projections By Distribution Channel 
6.4. Market Value Forecast By Distribution Channel, 2016–2026
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
6.4.4. Drug Stores
6.5. Prominent Trends
6.6. Market Attractiveness By Distribution Channel 

7. Global Branded Generics Market Analysis and Forecasts, By Major Drug Classes
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Major Drug Classes
7.3. Y-o-Y Growth Projections By Major Drug Classes
7.4. Market Value Forecast By Major Drug Classes, 2016–2026
7.4.1. Alkylating Agents
7.4.2. Antimetabolites
7.4.3. Hormones
7.4.4. Anti-Hypertensive
7.4.5. Lipid Lowering Drugs
7.4.6. Anti-Depressants
7.4.7. Anti-Psychotics
7.4.8. Anti-Epileptic
7.4.9. Others
7.5. Prominent Trends
7.6. Market Attractiveness By Major Drug Classes

8. Global Branded Generics Market Analysis and Forecasts, By Formulation Type 
8.1. Introduction
8.2. Basis Point Share (BPS) Analysis By Formulation Type 
8.3. Y-o-Y Growth Projections By Formulation Type 
8.4. Market Value Forecast By Formulation Type , 2016–2026
8.4.1. Oral 
8.4.2. Parenteral 
8.4.3. Topical 
8.4.4. Others
8.5. Prominent Trends
8.6. Market Attractiveness By Formulation Type 

9. Global Branded Generics Market Analysis and Forecasts, By Region
9.1. Basis Point Share (BPS) Analysis By Region
9.2. Y-o-Y Growth Projections By Region
9.3. Market Value Forecast By Region
9.3.1. North America 
9.3.2. Latin America 
9.3.3. Western Europe 
9.3.4. Eastern Europe 
9.3.5. APEJ 
9.3.6. Japan 
9.3.7. MEA 
9.4. Market Attractiveness By Region

10. North America Branded Generics Market Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2.Market Value Forecast By Therapeutic Application Type , 2016–2026
10.2.1. Oncology
10.2.2. Cardiovascular Diseases
10.2.3. Diabetes
10.2.4. Neurology
10.2.5. Gastrointestinal Diseases
10.2.6. Dermatology Diseases
10.2.7. Analgesics and Anti-inflammatory
10.2.8. Others
10.3.Market Value Forecast By Distribution Channel, 2016–2026
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.3.4. Drug Stores
10.4.Market Value Forecast By Major Drug Classes, 2016–2026
10.4.1. Alkylating Agents
10.4.2. Antimetabolites
10.4.3. Hormones
10.4.4. Anti-Hypertensive
10.4.5. Lipid Lowering Drugs
10.4.6. Anti-Depressants
10.4.7. Anti-Psychotics
10.4.8. Anti-Epileptic
10.4.9. Others
10.5.Market Value Forecast By Formulation Type , 2016–2026
10.5.1. Oral 
10.5.2. Parenteral 
10.5.3. Topical 
10.5.4. Others
10.6.Market Value Forecast By Country, 2016–2026
10.6.1. US
10.6.2. Canada
10.7.Market Attractiveness Analysis 
10.7.1. By Therapeutic Application Type 
10.7.2. By Distribution Channel 
10.7.3. By Major Drug Classes
10.7.4. By Formulation Type 
10.7.5. By Country
10.8. Prominent Trends 
10.9. Drivers and Restraints: Impact Analysis

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote